Detalhe da pesquisa
1.
Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis.
N Engl J Med
; 388(26): 2444-2455, 2023 Jun 29.
Artigo
Inglês
| MEDLINE | ID: mdl-37379135
2.
The safety of vedolizumab for ulcerative colitis and Crohn's disease.
Gut
; 66(5): 839-851, 2017 05.
Artigo
Inglês
| MEDLINE | ID: mdl-26893500
3.
Vedolizumab as induction and maintenance therapy for ulcerative colitis.
N Engl J Med
; 369(8): 699-710, 2013 Aug 22.
Artigo
Inglês
| MEDLINE | ID: mdl-23964932
4.
Vedolizumab as induction and maintenance therapy for Crohn's disease.
N Engl J Med
; 369(8): 711-21, 2013 Aug 22.
Artigo
Inglês
| MEDLINE | ID: mdl-23964933
5.
Effects of vedolizumab induction therapy for patients with Crohn's disease in whom tumor necrosis factor antagonist treatment failed.
Gastroenterology
; 147(3): 618-627.e3, 2014 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-24859203
6.
Relative bioavailability of a prototype oral solution of the Aurora A kinase inhibitor alisertib (MLN8237) in patients with advanced solid tumors.
Int J Clin Pharmacol Ther
; 53(7): 563-72, 2015 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-26073352
7.
Efficacy and safety of mirikizumab as induction and maintenance therapy for Japanese patients with moderately to severely active ulcerative colitis: a subgroup analysis of the global phase 3 LUCENT-1 and LUCENT-2 studies.
Intest Res
; 22(2): 172-185, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38720466
8.
Mirikizumab-Induced Transcriptome Changes in Ulcerative Colitis Patient Biopsies at Week 12 Are Maintained Through Week 52.
Clin Transl Gastroenterol
; 14(11): e00630, 2023 11 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37594044
9.
A Programme for Risk Assessment and Minimisation of Progressive Multifocal Leukoencephalopathy Developed for Vedolizumab Clinical Trials.
Drug Saf
; 41(8): 807-816, 2018 08.
Artigo
Inglês
| MEDLINE | ID: mdl-29737503
10.
A Review of the Clinical Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Vedolizumab.
Clin Pharmacokinet
; 56(11): 1287-1301, 2017 11.
Artigo
Inglês
| MEDLINE | ID: mdl-28523450
11.
Voluntary electronic reporting of medical errors and adverse events. An analysis of 92,547 reports from 26 acute care hospitals.
J Gen Intern Med
; 21(2): 165-70, 2006 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-16390502
12.
Differences in triage thresholds for patients presenting with possible acute coronary syndromes: more than meets the eye.
J Investig Med
; 54(2): 76-85, 2006 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-16472477
13.
Effect of Food on the Pharmacokinetics of the Investigational Aurora A Kinase Inhibitor Alisertib (MLN8237) in Patients with Advanced Solid Tumors.
Drugs R D
; 16(1): 45-52, 2016 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-26689566
14.
Vedolizumab, a monoclonal antibody to the gut homing α4ß7 integrin, does not affect cerebrospinal fluid T-lymphocyte immunophenotype.
J Neuroimmunol
; 264(1-2): 123-6, 2013 Nov 15.
Artigo
Inglês
| MEDLINE | ID: mdl-24067534
15.
Smoking cessation in primary care: a clinical effectiveness trial of two simple interventions.
Prev Med
; 38(3): 284-94, 2004 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-14766110